Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer's disease in mild cognitive impairment patients.

Andrea CiarmielloAntonio TartaglioneElisabetta GiovanniniMattia RiondatoGiampiero GiovacchiniOrnella FerrandoMarina De BiasiChiara PasseraElena CarabelliAntonio MannironiFranca FoppianoBruno AlfanoLuigi Mansi

Published in: European journal of nuclear medicine and molecular imaging (2018)

EudraCT 2015-001184-39.

Keyphrases

mild cognitive impairment
cognitive decline
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
genome wide
risk factors